Report #2871625

Received Nov 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 67 yrs
State: CA
Recovered: Unknown
Vaccinated: Oct 15, 2025
Onset: Oct 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	9M2R7	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Menveo administration in a 67-year-old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 67-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 9M2R7, expiry date 21-DEC-2025) for prophylaxis. On 15-OCT-2025, the patient received Menveo. On 15-OCT-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Menveo administration in a 67-year-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt date: 20-OCT-2025 A pharmacist inquired about how to proceed after a 67-year-old patient had received Menveo. The pharmacist requested information regarding safety data for administration in individuals over 55 years of age and asked why this vaccine was not recommended for patients older than that. The reporter did not consent to follow-up.